Fernández-Real JM, Broch M, Vendrell J, Richart C, Ricart W
Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85, 1334-1339
dx.doi.org/10.1210/jc.85.3.1334
Fernandez-Real JM, Granada ML, Ruzafa A, Casamitjana R, Ricart W
Insulin sensitivity and secretion influence the relationship between growth hormone-binding-protein and leptin.
CLINICAL ENDOCRINOLOGY, 2000, 52, 159-164
dx.doi.org/10.1046/j.1365-2265.2000.00907.x
Fernández-Real JM, Grasa M, Casamitjana R, Ricart W
The insulin resistance syndrome and the binding capacity of cortisol binding globulin (CBG) in men and women.
CLINICAL ENDOCRINOLOGY, 2000, 52, 93-99
Fernández-Real JM, Vayreda M, Casamitjana R, Gonzalez-Huix F, Ricart W
The fat-free mass compartment influences serum leptin in men.
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2000, 142, 25-29
dx.doi.org/10.1530/eje.0.1420025
Brugada R
Use of intravenous antiarrhythmics to identify concealed Brugada syndrome.
CURR CONTR TRIALS C, 2000, 1, 45-47
dx.doi.org/10.1186/cvm-1-1-045
Ricart W, Bach C, Fernández-Real JM, Sabrià J
Major fetal complications in optimised progestational diabetes mellitus.
Diabetologia, 2000, 43, 1077-1078
Fernández-Real JM, Ricart W
Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness
Diabetologia, 1999, 42, 1367-1374
dx.doi.org/10.1007/s001250051451
Biarnés J, Barrientos A, Ricart W, Nunes V, Fernández-Castañer M, Soler J
Diabetes mellitus asociada a la mutación A3243G de ADN mitocondrial. A proposito de un caso.
MEDICINA CLINICA, 1999, 112, 99-101
Fernández-Real JM, Gutiérrez C, Ricart W, Castiñeira MJ, Vendrell J, Richart C
Plasma levels of the soluble fraction of tumor necrosis factor receptors 1 and 2 are independent determinants of plasma cholesterol and LDL-cholesterol concentrations in healthy subjects.
Atherosclerosis, 1999, 146, 321-327
dx.doi.org/10.1016/S0021-9150(99)00156-2
Camps I, Biarnés J, Fernández-Real JM, Insa R, Soler J, Fernández Castañer M
Resistencia a la insulina y síndrome metabólico en familiares de primer grado de pacientes con diabetes mellitus tipo 2.
MEDICINA CLINICA, 1999, 112, 281-284
Ricart W, Bach C, Fernández-Real JM, Biarnés J, Sabrià J
Impacto de un cribado selectivo de la diabetes gestacional en una población española.
MEDICINA CLINICA, 1999, 113, 331-333
Fernandez-Real JM, Vendrell J, Baiget M, Gimferrer E, Ricart W
C282Y and H63D mutations of the hemochromatosis candidate gene in type 2 diabetes.
Diabetes Care, 1999, 22, 525-526
dx.doi.org/10.2337/diacare.22.3.525
Fernández-Real JM, Grasa M, Casamitjana R, Pugeat M, Barret C, Ricart W
Plasma total and glycosylated corticosteroid-binding globulin levels are associated with insulin secretion.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84, 3192-3196
dx.doi.org/10.1210/jc.84.9.3192
Rosenfeld RG, Hwa V, Wilson L, Lopez-Bermejo A, Buckway C, Burren C, Choi WK, Devi G, Ingermann A, Graham D, Minniti G, Spagnoli A, Oh Y
The insulin-like growth factor binding protein superfamily: new perspectives.
Pediatrics, 1999, 104, 1018-1021
Cos M, Fernández-Real JM, Ricart W, Ortiz MR
Síndrome del tiroides negro. Descripción de un caso.
REVISTA CLINICA ESPANOLA, 1999, 199, 478-479
Fernández-Real JM, Gutiérrez C, Broch M, Casamitjana R, Vendrell J, Ricart W
Insulin response to intravenous glucose correlates with plasma levels of the tumor necrosis factor receptor-1.
Diabetes Care, 1999, 22, 868-870
dx.doi.org/10.2337/diacare.22.5.868
Fernández-Real JM, Molina A, Broch M, Ricart W, Gutiérrez C, Casamitjana R, Vendrell J, Soler J, Gómez-Sáez JM
Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy.
Diabetes, 1999, 48, 1108-1112
dx.doi.org/10.2337/diabetes.48.5.1108
close arrow-circle-o-down arrow-left bars linkedin angle-double-up youtube-play instagram 
